Antithrombotic Therapy After Acute Coronary Syndrome: Balancing Ischaemic Protection and Bleeding Risk

Antithrombotic therapy is central to preventing recurrent ischaemic events after acute coronary syndrome (ACS), yet it also increases bleeding, which is itself associated with adverse outcomes. This review summarises the mechanisms of coronary thrombosis, the pharmacology of antiplatelet and anticoagulant agents, and the evidence guiding the duration and intensity of dual antiplatelet therapy (DAPT). Twelve months of DAPT remains the default for most patients without high bleeding risk. In selected, clinically stable patients after percutaneous coronary intervention (PCI), shortened DAPT followed by P2Y12-inhibitor monotherapy reduced bleeding without an increase in ischaemic events in several randomised trials. However, immediate aspirin withdrawal after PCI did not show non-inferiority for ischaemic outcomes in NEO-MINDSET, with the excess events concentrated in the first month. Bleeding-risk tools, including the Academic Research Consortium high-bleeding-risk criteria and the PRECISE-DAPT score, together with patient characteristics, should inform treatment duration, particularly in older adults, patients with chronic kidney disease and those requiring oral anticoagulation. Evidence from Indian populations remains limited. Individualised treatment, reassessed as clinical circumstances change, offers the best balance between ischaemic protection and bleeding risk.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24394565
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Antithrombotic Therapy After Acute Coronary Syndrome: Balancing Ischaemic Protection and Bleeding Risk

Abinash. K., Monica. K., Manisha. M.
1 links
Zenodo (CERN European Organization for Nuclear Research)
Antiplatelet Therapy and Cardiovascular Diseases
article

Antithrombotic Therapy After Acute Coronary Syndrome: Balancing Ischaemic Protection and Bleeding Risk

Abinash. K., Monica. K., Manisha. M.
article en

Abstract

Antithrombotic therapy is central to preventing recurrent ischaemic events after acute coronary syndrome (ACS), yet it also increases bleeding, which is itself associated with adverse outcomes. This review summarises the mechanisms of coronary thrombosis, the pharmacology of antiplatelet and anticoagulant agents, and the evidence guiding the duration and intensity of dual antiplatelet therapy (DAPT). Twelve months of DAPT remains the default for most patients without high bleeding risk. In selected, clinically stable patients after percutaneous coronary intervention (PCI), shortened DAPT followed by P2Y12-inhibitor monotherapy reduced bleeding without an increase in ischaemic events in several randomised trials. However, immediate aspirin withdrawal after PCI did not show non-inferiority for ischaemic outcomes in NEO-MINDSET, with the excess events concentrated in the first month. Bleeding-risk tools, including the Academic Research Consortium high-bleeding-risk criteria and the PRECISE-DAPT score, together with patient characteristics, should inform treatment duration, particularly in older adults, patients with chronic kidney disease and those requiring oral anticoagulation. Evidence from Indian populations remains limited. Individualised treatment, reassessed as clinical circumstances change, offers the best balance between ischaemic protection and bleeding risk.

Zenodo (CERN European Organization for Nuclear Research)
Tamil Nadu Dr. M.G.R. Medical University (IN)
Good health and well-being
Antiplatelet Therapy and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon